IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+12.89%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$317M
AUM Growth
+$317M
(-3.5%)
Cap. Flow
-$31.6M
Cap. Flow
% of AUM
-9.97%
Top 10 Holdings %
Top 10 Hldgs %
36.88%
Holding
89
New
29
Increased
20
Reduced
19
Closed
19
Top Buys
| 1 |
Revvity
RVTY
|
$10M |
| 2 |
Abbott
ABT
|
$6.53M |
| 3 |
Sanofi
SNY
|
$6.27M |
| 4 |
Centene
CNC
|
$5.54M |
| 5 |
eHealth
EHTH
|
$5.53M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
$13.7M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
$10.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
$9.05M |
| 4 |
Danaher
DHR
|
$7.96M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.65M |
Sector Composition
| 1 | Healthcare | 88.17% |
| 2 | Energy | 5.03% |
| 3 | Financials | 1.75% |
| 4 | Consumer Discretionary | 0.61% |
| 5 | Technology | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
MacroGenics
MGNX
$112M
| $2.27M | 0.69% | 90,000 +20,000 | +29% | +$504K |
|
52
Zai Lab
ZLAB
$3.68B
| $2.08M | 0.64% | +25,000 | New | +$2.08M |
|
53
Acadia Healthcare
ACHC
$2.12B
| $2.06M | 0.63% | +70,000 | New | +$2.06M |
|
54
Glaukos
GKOS
$5.5B
| $1.98M | 0.61% | +40,000 | New | +$1.98M |
|
55
Chewy
CHWY
$16.9B
| $1.92M | 0.59% | +35,000 | New | +$1.92M |
|
|
SWAV
56
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.9M | 0.58% | +25,000 | New | +$1.9M |
|
57
Precision BioSciences
DTIL
$57.8M
| $1.85M | 0.57% | +300,000 | New | +$1.85M |
|
58
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $1.84M | 0.56% | +120,000 | New | +$1.84M |
|
|
GNMK
59
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.78M | 0.54% | 125,000 +25,000 | +25% | +$355K |
|
60
Kura Oncology
KURA
$686M
| $1.53M | 0.47% | +50,000 | New | +$1.53M |
|
|
DRNA
61
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.44M | 0.44% | 80,000 -30,000 | -27% | -$540K |
|
62
PTC Therapeutics
PTCT
$3.92B
| $1.41M | 0.43% | 30,100 +100 | +0.3% | +$4.67K |
|
63
Genmab
GMAB
$15.3B
| $1.1M | 0.34% | +30,000 | New | +$1.1M |
|
64
Seres Therapeutics
MCRB
$166M
| $849K | 0.26% | +30,000 | New | +$849K |
|
65
Insmed
INSM
$28.8B
| $804K | 0.25% | +25,000 | New | +$804K |
|
|
CHNG
66
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $726K | 0.22% | 50,000 -200,000 | -80% | -$2.9M |
|
|
MYOV
67
DELISTED
Myovant Sciences Ltd.
MYOV
| $703K | 0.22% | +50,000 | New | +$703K |
|
68
Alector
ALEC
$238M
| $316K | 0.1% | +30,000 | New | +$316K |
|
69
AbbVie
ABBV
$372B
| – | – | -25,000 | Closed | -$2.46M |
|
|
BMY.RT
70
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – | -150,000 | Closed | -$537K |
|
|
MNTA
71
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – | -150,000 | Closed | -$4.99M |
|
|
ZGNX
72
DELISTED
Zogenix, Inc.
ZGNX
| – | – | -90,000 | Closed | -$2.43M |
|
73
Akebia Therapeutics
AKBA
$833M
| – | – | -250,000 | Closed | -$3.4M |
|
74
Amgen
AMGN
$155B
| – | – | -25,000 | Closed | -$5.9M |
|
|
AMRN
75
Amarin Corp
AMRN
$311M
| – | – | -350,000 | Closed | -$2.42M |
|